openPR Logo
Press release

Insulin Pumps Market Outlook to 2025 - Tandem Diabetes Care, Debiotech, CELLNOVO, SOOIL Developments, MicroPort, Insulet Corporation, Medtronic, Scientific Corporation, Valeritas, Ypsomed AGand

02-07-2019 04:34 AM CET | Health & Medicine

Press release from: The Insight Partners

Insulin Pumps Market

Insulin Pumps Market

The insulin pumps market research study involved the extensive use of both primary and secondary sources. The global market research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Increasing prevalence of type I diabetes is driving the market for insulin pumps over the forecast period

The increasing funding for research activities is also helps to increasing the growth for the global insulin pumps market in the coming years. In North America, diabetes management is gaining significant importance. With increasing funding for research, new product development is increasing are a rapid pace in the US and other countries. For instance, the Consolidated Appropriations Act for Fiscal Year 2016 increased discretionary funding for the National Institute of Diabetes and Digestive and Kidney Diseases to US$1.81 billion, an increase of over US$68 million compared to FY2015.

Get PDF sample copy: http://bit.ly/2TBzFsy

The major players operating in the market of insulin pumps include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc, Debiotech S.A, CELLNOVO, SOOIL Developments Co., Ltd, MicroPort, Scientific Corporation, Valeritas Inc., F. Hoffmann-La Roche Ltd., Ypsomed AGand, Inc. and among others.

The global insulin pumps market estimated to grow at a CAGR of 10.5% during the forecast period from 2018 to 2025. The insulin pumps market for insulin pumps was valued at USD 3,822.44 Mn in 2017 and is estimated to reach US$ 8,264.01 Mn by 2025.

The factors that are responsible for the type I diabetes include genetics, exposure to viruses and other environmental factors that develops in adults but also typically appears during childhood or adolescence phase. According to the Centers for Disease Control and Prevention (CDC), in 2017, approximately 23 million people had diagnosed with diabetes in the United States, whereas people with type I diabetes accounted for approximately 5% to 10%, or approximately 1.2 to 2.3 million in the country. Furthermore, the IDF also projected with type I diabetes that represent approximately 10% of the diabetes population worldwide. Thus, the increasing prevalence of type I diabetes help to boost the growth of the global insulin market in the coming years.

The increasing technological advancements due to the increased demand for product development. However, the availability of alternatives for insulin delivery pumps are expected to act as major challenges hindering the market growth.

Buy this report: http://bit.ly/2TARhVz

Over the years, researchers have been carrying out research activities which have resulted to product innovations. Products with increased technology with more effective benefits is a major requirement in the treatment for diabetes. As the prevalence of diabetes is increasing across the world, the demand for more products with advancements is also boosting up. The growing innovations in novel insulin pump products is a boosting factor that helps to propelling the growth for the market.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Pumps Market Outlook to 2025 - Tandem Diabetes Care, Debiotech, CELLNOVO, SOOIL Developments, MicroPort, Insulet Corporation, Medtronic, Scientific Corporation, Valeritas, Ypsomed AGand here

News-ID: 1566934 • Views: 594

More Releases from The Insight Partners

Winery Equipment Market Outlook, Business Status, Industry Trends | Krones AG, P …
Chicago, United States, 2020: The global Winery Equipment Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Winery Equipment Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of
Luxury Shuttle Bus Market Growing Popularity and Emerging Trends | Daimler AG, F …
Growing environmental concerns and rising awareness related to public transportation benefits is the major driving factor for the growth of the luxury shuttle bus market. Further, significant improvements in the design and interiors of luxury shuttle buses, consistent advancements in technology, and government initiatives for public transportation development are also positively impacting the growth of the luxury shuttle bus market. The study report on Global Luxury Shuttle Bus Market 2020 to
Sodium Metasilicate Pentahydrate Market New Tech Developments and Advancements t …
Sodium Metasilicate Pentahydrate Market research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers, and challenges. This report strategically examines the micro-markets and sheds light on the
Male Hypogonadism Market to 2027 - AbbVie Inc., Teva Pharmaceutical, Merck, Fino …
A report by The Insight Partner's on the Male Hypogonadism Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the market by monitoring the strengths and weaknesses of prominent contributors and their key products. Male hypogonadism is a failure of the testes that produce the male test hormone testosterone, sperm, or

All 5 Releases


More Releases for Insulin

Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin Delivery Devices Market - Insights
Insulin is vital for people suffering from type 1 diabetes and type 2 diabetes. In the past, patients with diabetes had to inject insulin using large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. Improvements and innovations has led to development of insulin delivery devices such as pens and insulin pumps. Furthermore, insulin analogs have become available that enable both continuous subcutaneous insulin
Biosimilar Insulin Market Access
Boston, MA ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer
Biosimilar Insulin Market Access
ReportsWorldwide has announced the addition of a new report title Biosimilar Insulin Market Access to its growing collection of premium market research reports. Biosimilar competition is providing payers with opportunities to contain costs in a category that accounts for a significant proportion of total drug expenditure. The launch of the biosimilar insulin Basaglar is a threat to the insulin-based product market, which includes long-time reference product Lantus as well as newer entrants
Biosimilar Insulin Market Biosimilar Insulin Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Insulin Biosimilars 1.1 Outline Towards Insulin 1.2 Trail of Insulin Evolution and Development Rationale Design of Insulin Molecule 2.1 Structure of Insulin Polypeptide 2.2 Biosynthesis of Insulin 2.3 Secretion of Insulin Mechanism of Insulin in Diabetics 3.1 Glucose Metabolism of Insulin 3.2 Impact of Insulin Dysregulation in Diabetes 1 3.3 Impact
Global Insulin Delivery Machine Market: By Types - Insulin Pens, Insulin Pumps, …
Latest industry research report on: Global Insulin Delivery Machine Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1181480 This report studies Insulin Delivery Machine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in